Psychedelic Mental Health

@PsychedelicInstitute
357 Followers
71 Following
1.1K Posts
Substantial amount of medical information provided by popular chatbots inaccurate and incomplete

A substantial amount of medical information provided by 5 popular chatbots is inaccurate and incomplete, with half of the answers to clear evidence based questions “somewhat” or “highly” problematic, show the results of a study published in the open access journal BMJ Open. Continued deployment of these chatbots without public education and oversight risks amplifying misinformation, warn the researchers.

EurekAlert!
Frontiers | Pharmacological interventions targeting the gut–brain axis in neurological disorders: mechanisms and translational applications

The microbiota–gut–brain axis represents a complex bidirectional communication network linking the gastrointestinal system and the central nervous system and...

Frontiers
The Shipibo Ceremonial Use of Ayahuasca to Promote Well-Being: An Observational Study (2021) https://pmc.ncbi.nlm.nih.gov/articles/PMC8131827/ #ayahuasca #mentalhealth #psychedelics results suggest that the Indigenous Shipibo healing work with ayahuasca has value to improve long-term well-being and quality of life —even for people of other cultures.
Checking your browser - reCAPTCHA

Psychedelic Therapy: Does the psychedelic experience matter?

Psychedelic medicines have been studied in the Western medical literature consistently for over 100 years, over 60 of which in the ongoing study and practice of racemic ketamine. Psychedelic experiences are described similarly and often felt as profoundly meaningful.

Psychedelic Mental Health Institute
18 medicamentos psicodelicos pueden legalizarse en las proximas semanas en USA ✌🏻
#psicodélicos #saludmental
https://www.youtube.com/watch?v=KhCYBDN3tJk
18 medicamentos psicodelicos pueden legalizarse en las proximas semanas en eeuu: ministro salud

YouTube
Is ketamine a "psychedelic"?

Yes.

Psychedelic Mental Health Institute
https://pubmed.ncbi.nlm.nih.gov/41997505/ Ketamine for Depression in Serious Illness: Evidence, Safety, and Practical Approaches (2026) “Safety across serious illness studies is generally favorable, with transient dissociation, hypertension, and somnolence the most common adverse effects; serious adverse events remain rare. #Ketamine and #esketamine offer the strongest evidence among rapid-acting antidepressants and may be preferred when urgent symptom relief is needed.” #mentalhealth #psychedelics
Ketamine for Depression in Serious Illness: Evidence, Safety, and Practical Approaches - PubMed

Patients with serious illness and short prognoses often experience depression and suicidal ideation. Traditional antidepressants are limited by delayed onset, creating a need for rapidly acting therapies. In this Palliative Care Rounds, we examine the evidence for ketamine/esketamine's efficacy as a …

PubMed
Spotlight: Psychedelics in Palliative Care, Ready for Primetime! Making the Case for Ketamine-Assisted Psychotherapy (Horowitz, et al, 2024)

"Preliminary evidence demonstrates that Ketamine-Assisted Psychotherapy (KAP) can significantly improve depression, demoralization and existential distress in seriously ill people"

Psychedelic Mental Health Institute
https://pubmed.ncbi.nlm.nih.gov/41987516/ #ketamine for acute pain in older adults in the er (2026) #esketamine
Acute pain management in older adults presenting to the emergency department: a clinical review - PubMed

Managing acute pain in older adults is a complex challenge in emergency care, influenced by age-related physiological changes, multimorbidity and altered pharmacokinetics. Inadequate treatment contributes to frailty, delirium, functional decline and reduced quality of life, yet oligoanalgesia remain …

PubMed